Previous 10 | Next 10 |
Inari Medical continues to live up to expectations, showing very solid growth and strong margins. I like the business a lot, yet have not initiated a position yet. While I am running behind the facts, I continue to like the company a lot, wishing for a pullback providing a solid e...
US IPO market activity is picking back up ahead of the Thanksgiving holiday, with six IPOs scheduled to raise $3.4 billion in the week ahead. Biotech research product provider Maravai LifeSciences plans to raise $1.3 billion at a $6.6 billion market cap. Street research is expecte...
Savvy growth investors are always on the hunt for small and mid-cap companies that can one day balloon into mega-caps, taking even small initial investments on an awesome ride. One great example of a company that's experienced this transformation is Intuitive Surgical , the manufacturer...
IRVINE, Calif., Nov. 13, 2020 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a commercial-stage medical device company focused on developing products to treat and transform the lives of patients suffering from venous diseases, today announced follow-up resul...
Inari Medical, Inc. (NARI) Q3 2020 Earnings Conference Call November 12, 2020, 04:30 PM ET Company Participants Caroline Corner - Investor Relations, Westwicke Partners Bill Hoffman - Chief Executive Officer Mitch Hill - Chief Financial Officer Conference Call Participants Bob Hopkins - Bank ...
Inari Medical (NARI): Q3 GAAP EPS of $0.12 beats by $0.18.Revenue of $38.72M (+172.1% Y/Y) beats by $12.19M.Cash and equivalents were $168M, which reflects a $30.3M payoff of our long-term debt during Q3.Due to uncertainty surrounding the COVID-19 pandemic, Inari Medical will not provide fina...
IRVINE, Calif., Nov. 12, 2020 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a commercial-stage medical device company focused on developing products to treat and transform the lives of patients suffering from venous diseases, today reported financial result...
IRVINE, Calif., Nov. 12, 2020 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a commercial-stage medical device company focused on developing products to treat and transform the lives of patients suffering from venous diseases, today announced the appointment...
[[AMAT]], [[AMWL]], [[AQN]], [[CSCO]], [[DGII]], [[DIS]], [[DLB]], [[FTCH]], [[GLOB]], [[JAMF]], [[NARI]], [[PLTR]], [[U]]For Seeking Alpha's full earnings season calendar, click here. For further details see: Notable earnings after Thursday's close
IRVINE, Calif., Nov. 06, 2020 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”) announced today that its management team will participate at the Canaccord Genuity Virtual MedTech & Diagnostics Forum on Thursday, November 19, 2020. About Inari Medical...
News, Short Squeeze, Breakout and More Instantly...
IRVINE, Calif., July 16, 2024 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, today announced that it will release its second quarter 2024...
Hagens Berman Encourages NARI Investors with Substantial Losses to Contact Firm Before July 12, 2024 Deadline San Francisco, California--(Newsfile Corp. - June 26, 2024) - Hagens Berman urges Inari Medical, Inc. (NASDAQ: NARI) investors who suffered substantial losses to submit your losses no...
2024-06-01 18:36:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...